APO RESEARCH · REPORT
Animal Stem Cell Therapy
Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
Product & engineering
Understand the product.
Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
Selected research
Industry Research
Animal Stem Cell Therapy Industry Research Report 2026
Market perspective
Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
Market competition is intense. Medivet Biologics LLC, VETSTEM BIOPHARMA and J-ARM, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption region of animal stem cell therapy, with a consumption market share nearly 58%. Japan is the second largest supplier of animal stem cell therapy, enjoying production market share nearly 15%.
Read the full market overview
Report Scope
This report quantifies the global Animal Stem Cell Therapy market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Animal Stem Cell Therapy.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Animal Stem Cell Therapy Market by Company
Medivet Biologics LLC
VETSTEM BIOPHARMA
J-ARM
U.S. Stem Cell, Inc
VetCell Therapeutics
Celavet Inc.
Magellan Stem Cells
Kintaro Cells Power
Animal Stem Care
Animal Cell Therapies
Cell Therapy Sciences
Animacel
Animal Stem Cell Therapy Segment by Type
Dogs Stem Cell Therapy
Horses Stem Cell Therapy
Others Animals
Animal Stem Cell Therapy Segment by Application
Veterinary Hospitals
Research Organizations
Animal Stem Cell Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Stem Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Stem Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Stem Cell Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Animal Stem Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Dogs Stem Cell Therapy
- Horses Stem Cell Therapy
- Others Animals
Applications
- Veterinary Hospitals
- Research Organizations
Companies covered
- Medivet Biologics LLC
- VETSTEM BIOPHARMA
- J-ARM
- U.S. Stem Cell, Inc
- VetCell Therapeutics
- Celavet Inc.
- Magellan Stem Cells
- Kintaro Cells Power
- Animal Stem Care
- Animal Cell Therapies
- Cell Therapy Sciences
- Animacel
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Animal Stem Cell Therapy by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Dogs Stem Cell Therapy
- 2.2.3 Horses Stem Cell Therapy
- 2.2.4 Others Animals
- 2.3 Animal Stem Cell Therapy by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Veterinary Hospitals
- 2.3.3 Research Organizations
- 2.4 Assumptions and Limitations
3 Animal Stem Cell Therapy Breakdown Data by Type
- 3.1 Global Animal Stem Cell Therapy Historic Market Size by Type (2021-2026)
- 3.2 Global Animal Stem Cell Therapy Forecasted Market Size by Type (2027-2032)
4 Animal Stem Cell Therapy Breakdown Data by Application
- 4.1 Global Animal Stem Cell Therapy Historic Market Size by Application (2021-2026)
- 4.2 Global Animal Stem Cell Therapy Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Animal Stem Cell Therapy Market Perspective (2021-2032)
- 5.2 Global Animal Stem Cell Therapy Growth Trends by Region
- 5.2.1 Global Animal Stem Cell Therapy Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Animal Stem Cell Therapy Historic Market Size by Region (2021-2026)
- 5.2.3 Animal Stem Cell Therapy Forecasted Market Size by Region (2027-2032)
- 5.3 Animal Stem Cell Therapy Market Dynamics
- 5.3.1 Animal Stem Cell Therapy Industry Trends
- 5.3.2 Animal Stem Cell Therapy Market Drivers
- 5.3.3 Animal Stem Cell Therapy Market Challenges
- 5.3.4 Animal Stem Cell Therapy Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Animal Stem Cell Therapy Players by Revenue
- 6.1.1 Global Top Animal Stem Cell Therapy Players by Revenue (2021-2026)
- 6.1.2 Global Animal Stem Cell Therapy Revenue Market Share by Players (2021-2026)
- 6.2 Global Animal Stem Cell Therapy Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Animal Stem Cell Therapy Head Office and Area Served
- 6.4 Global Animal Stem Cell Therapy Players, Product Type & Application
- 6.5 Global Animal Stem Cell Therapy Manufacturers Established Date
- 6.6 Global Animal Stem Cell Therapy Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Animal Stem Cell Therapy Market Size (2021-2032)
- 7.2 North America Animal Stem Cell Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Animal Stem Cell Therapy Market Size by Country (2021-2026)
- 7.4 North America Animal Stem Cell Therapy Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Animal Stem Cell Therapy Market Size (2021-2032)
- 8.2 Europe Animal Stem Cell Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Animal Stem Cell Therapy Market Size by Country (2021-2026)
- 8.4 Europe Animal Stem Cell Therapy Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Animal Stem Cell Therapy Market Size (2021-2032)
- 9.2 Asia-Pacific Animal Stem Cell Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Animal Stem Cell Therapy Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Animal Stem Cell Therapy Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Animal Stem Cell Therapy Market Size (2021-2032)
- 10.2 South America Animal Stem Cell Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Animal Stem Cell Therapy Market Size by Country (2021-2026)
- 10.4 South America Animal Stem Cell Therapy Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Animal Stem Cell Therapy Market Size (2021-2032)
- 11.2 Middle East & Africa Animal Stem Cell Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Animal Stem Cell Therapy Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Animal Stem Cell Therapy Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Medivet Biologics LLC
- 12.1.1 Medivet Biologics LLC Company Information
- 12.1.2 Medivet Biologics LLC Business Overview
- 12.1.3 Medivet Biologics LLC Revenue in Animal Stem Cell Therapy Business (2021-2026)
- 12.1.4 Medivet Biologics LLC Animal Stem Cell Therapy Product Portfolio
- 12.1.5 Medivet Biologics LLC Recent Developments
- 12.2 VETSTEM BIOPHARMA
- 12.2.1 VETSTEM BIOPHARMA Company Information
- 12.2.2 VETSTEM BIOPHARMA Business Overview
- 12.2.3 VETSTEM BIOPHARMA Revenue in Animal Stem Cell Therapy Business (2021-2026)
- 12.2.4 VETSTEM BIOPHARMA Animal Stem Cell Therapy Product Portfolio
- 12.2.5 VETSTEM BIOPHARMA Recent Developments
- 12.3 J-ARM
- 12.3.1 J-ARM Company Information
- 12.3.2 J-ARM Business Overview
- 12.3.3 J-ARM Revenue in Animal Stem Cell Therapy Business (2021-2026)
- 12.3.4 J-ARM Animal Stem Cell Therapy Product Portfolio
- 12.3.5 J-ARM Recent Developments
- 12.4 U.S. Stem Cell, Inc
- 12.4.1 U.S. Stem Cell, Inc Company Information
- 12.4.2 U.S. Stem Cell, Inc Business Overview
- 12.4.3 U.S. Stem Cell, Inc Revenue in Animal Stem Cell Therapy Business (2021-2026)
- 12.4.4 U.S. Stem Cell, Inc Animal Stem Cell Therapy Product Portfolio
- 12.4.5 U.S. Stem Cell, Inc Recent Developments
- 12.5 VetCell Therapeutics
- 12.5.1 VetCell Therapeutics Company Information
- 12.5.2 VetCell Therapeutics Business Overview
- 12.5.3 VetCell Therapeutics Revenue in Animal Stem Cell Therapy Business (2021-2026)
- 12.5.4 VetCell Therapeutics Animal Stem Cell Therapy Product Portfolio
- 12.5.5 VetCell Therapeutics Recent Developments
- 12.6 Celavet Inc.
- 12.6.1 Celavet Inc. Company Information
- 12.6.2 Celavet Inc. Business Overview
- 12.6.3 Celavet Inc. Revenue in Animal Stem Cell Therapy Business (2021-2026)
- 12.6.4 Celavet Inc. Animal Stem Cell Therapy Product Portfolio
- 12.6.5 Celavet Inc. Recent Developments
- 12.7 Magellan Stem Cells
- 12.7.1 Magellan Stem Cells Company Information
- 12.7.2 Magellan Stem Cells Business Overview
- 12.7.3 Magellan Stem Cells Revenue in Animal Stem Cell Therapy Business (2021-2026)
- 12.7.4 Magellan Stem Cells Animal Stem Cell Therapy Product Portfolio
- 12.7.5 Magellan Stem Cells Recent Developments
- 12.8 Kintaro Cells Power
- 12.8.1 Kintaro Cells Power Company Information
- 12.8.2 Kintaro Cells Power Business Overview
- 12.8.3 Kintaro Cells Power Revenue in Animal Stem Cell Therapy Business (2021-2026)
- 12.8.4 Kintaro Cells Power Animal Stem Cell Therapy Product Portfolio
- 12.8.5 Kintaro Cells Power Recent Developments
- 12.9 Animal Stem Care
- 12.9.1 Animal Stem Care Company Information
- 12.9.2 Animal Stem Care Business Overview
- 12.9.3 Animal Stem Care Revenue in Animal Stem Cell Therapy Business (2021-2026)
- 12.9.4 Animal Stem Care Animal Stem Cell Therapy Product Portfolio
- 12.9.5 Animal Stem Care Recent Developments
- 12.10 Animal Cell Therapies
- 12.10.1 Animal Cell Therapies Company Information
- 12.10.2 Animal Cell Therapies Business Overview
- 12.10.3 Animal Cell Therapies Revenue in Animal Stem Cell Therapy Business (2021-2026)
- 12.10.4 Animal Cell Therapies Animal Stem Cell Therapy Product Portfolio
- 12.10.5 Animal Cell Therapies Recent Developments
- 12.11 Cell Therapy Sciences
- 12.11.1 Cell Therapy Sciences Company Information
- 12.11.2 Cell Therapy Sciences Business Overview
- 12.11.3 Cell Therapy Sciences Revenue in Animal Stem Cell Therapy Business (2021-2026)
- 12.11.4 Cell Therapy Sciences Animal Stem Cell Therapy Product Portfolio
- 12.11.5 Cell Therapy Sciences Recent Developments
- 12.12 Animacel
- 12.12.1 Animacel Company Information
- 12.12.2 Animacel Business Overview
- 12.12.3 Animacel Revenue in Animal Stem Cell Therapy Business (2021-2026)
- 12.12.4 Animacel Animal Stem Cell Therapy Product Portfolio
- 12.12.5 Animacel Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst